Skip to content

Released Aug 9, 2017, after the close

10-Q filed Aug 9, 2017, 40 days after period end · 0001144204-17-041660

Q2 2017 · 10-Q
Revenue$2.36Mno prior Q2 2016 on file+244.9% vs Q1 2017
Net Income-$13.60MN/M vs Q2 2016N/M vs Q1 2017
EPS Diluted-$780.00N/M vs Q2 2016N/M vs Q1 2017
Operating Income-$13,567,251N/M
Operating Cash Flowderived-$12,357,151N/M
Free Cash Flowderived-$12,357,151N/M
Margins · derived
Operating margin-575.1%
Net margin-576.4%

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2017Q2 2016Q2 2015Q2 2014
Revenue$2.36M———
Net Income-$13.60M-$10.15M-$6.94M-$2.47M
EPS Diluted-$780.00-$0.59-$0.41-$0.52

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR